Zoe Docherty
Papers
1
Total Citations
47
H-Index
1
About
Zoe Docherty is a leading clinical scientist in the field of cytogenetics and genomic medicine, best known for her transformative work in the diagnosis of genome imbalance. Her research focuses on the validation and clinical implementation of advanced molecular technologies, particularly array comparative genomic hybridisation (CGH), as a replacement for traditional postnatal karyotyping. Her landmark 2010 study, cited 47 times, provided critical evidence that array CGH offers a substantial increase in diagnostic yield for patients with suspected genomic disorders, fundamentally shifting clinical practice toward higher-resolution, genome-wide testing. This work has had a lasting impact on the standard of care in genetic diagnostics, enabling more precise identification of chromosomal abnormalities. Docherty’s contributions have been instrumental in bridging the gap between research and routine clinical application, ensuring that patients benefit from the most accurate and comprehensive testing available. Her achievements underscore her role as a key figure in the evolution of modern cytogenetics, making her a respected authority for students and researchers alike.
Research Focus
Key Achievements
Top Papers
- 1